Utilizing specimens from the TB Recurrence upon Treatment with HAART (TRuTH) study we have previously identified several inflammatory markers of risk of TB recurrence (IL-6, IL-1β and IL-1Rα) and protection (IFN- β) in HIV co-infected individuals on antiretroviral therapy (ART) (11). Here, IL6 is linked to tuberculosis.